Back to Trades
Curran Daniel J.
DirectorCIK 0001887599
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Curran Daniel J., Director, has filed 6 SEC reports (2025–2026), spread across 3 companies, totaling $1.7M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jul 17 | CPRX CATALYST PHARMACEUTICALS, INC. | Curran Daniel J. | Director | Disposed | $1.3M |
| Jun 12 | XLO Xilio Therapeutics, Inc. | Curran Daniel J. | Insider | Award | $40.0K |
| Nov 24 | CPRX CATALYST PHARMACEUTICALS, INC. | Curran Daniel J. | Director | Award | $412.5K |
| Aug 13 | ALXO ALX ONCOLOGY HOLDINGS INC | Curran Daniel J. | Insider | Award | $24.8K |
| Aug 13 | ALXO ALX ONCOLOGY HOLDINGS INC | Curran Daniel J. | Insider | Other | $0 |
| Aug 8 | CPRX CATALYST PHARMACEUTICALS, INC. | Curran Daniel J. | Director | Other | $0 |
6 filings